Atea Pharmaceuticals Inc (AVIR)
4.62
-0.65%
Atea Pharmaceuticals Inc (AVIR) is currently trading at $4.62. This represents a loss of 0.65% from the previous session. With a market capitalization of $0.36B, AVIR is a key component of the Health Care sector. Investors looking to trade AVIR should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade AVIR commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Atea Pharmaceuticals Inc (AVIR) shows a bearish trend. Analysts are watching the 4.70 level closely.
Fundamentals
Mkt Cap0.36B
P/E Ratio0.0000
Volume324,273
60-Day Technical Chart
Advanced Charting
Need more indicators for AVIR? Use the world's #1 platform.
Open AVIR on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $5
| Metric |
AVIR -0.65% |
UWMC -8.77% |
OPEN -2.54% |
SNAP +2.01% |
|---|---|---|---|---|
| Price | $4.62 | $4.16 | $4.98 | $5.07 |
| Mkt Cap | $0.36B | $6.70B | $4.74B | $8.54B |
| - | View → | View → | View → |
Latest Headlines
No approved hepatitis E drugs: experimental pill shows powerful lab results
Stock Titan • Feb 24, 2026
Bullish Atea Pharmaceuticals Insiders Loaded Up On US$5.40m Of Stock
Yahoo Finance • Jan 13, 2026
Insiders Enjoy US$723k Return After Buying Atea Pharmaceuticals Stock
simplywall.st • Sep 19, 2025
New hepatitis C and E treatments move toward key human clinical trials in 2026
Stock Titan • Jan 8, 2026
symbol__ Stock Quote Price and Forecast
CNN • Mar 26, 2024
● Gemini Agentic AI Analyst Insight for AVIR
Market Education
- These Whales are taking all the Ape money - aka Large Fund Mgmt Companies Jul 17, 2023
- Finding Stocks in the Squeeze Zone: Using Finviz Jul 30, 2023
- Institutions vs Retail Traders - Showdown, Apes are winning May 24, 2021
External Research